Christophe Glorieux

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Reactive Oxygen Species

Transcription Factor

Top Venues

Antioxidants (Basel, Switzerland)

Nature reviews. Drug discovery

Cancer communications (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Christophe Glorieux, Cinthya Enríquez, Constanza González, Gabriela Aguirre-Martínez, Pedro Buc Calderon
The Multifaceted Roles of NRF2 in Cancer: Friend or Foe? Antioxidants (Basel, Switzerland) 13 (1) (2024)
Christophe Glorieux, Shihua Liu, Dunyaporn Trachootham, Peng Huang
Targeting ROS in cancer: rationale and strategies. Nature reviews. Drug discovery 23 (8) (2024)
Christophe Glorieux, Shihua Liu, Dunyaporn Trachootham, Peng Huang
Targeting ROS in cancer: rationale and strategies. Nature reviews. Drug discovery (2024)
Christophe Glorieux, Cinthya Enríquez, Constanza González, Gabriela Aguirre-Martínez, Pedro Buc Calderon
The Multifaceted Roles of NRF2 in Cancer: Friend or Foe? Antioxidants (Basel, Switzerland) 13 (1) (2024)
Mingquan Zhang, Rong Xiang, Christophe Glorieux, Peng Huang
PLA2G2A Phospholipase Promotes Fatty Acid Synthesis and Energy Metabolism in Pancreatic Cancer Cells with K-ras Mutation. International journal of molecular sciences 23 (19) (2022)
Christophe Glorieux, Lei Cui, Peiting Zeng, Xiaojun Xia, Peng Huang
Diverse effects of chemotherapeutic agents on immune cell function and implications in immunochemotherapy. Cancer communications (London, England) 41 (5) (2021)
Christophe Glorieux, Xiaojun Xia, Peng Huang
The Role of Oncogenes and Redox Signaling in the Regulation of PD-L1 in Cancer. Cancers 13 (17) (2021)
Christophe Glorieux, Pedro Buc Calderon
Vitamin C (Ascorbate) and Redox Topics in Cancer. Antioxidants & redox signaling 35 (14) (2021)